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represent	 host	 evolutionary	 adaptations	 to	 counteract	 this	 interaction.	 N. gonor‐





tially	 to	 human	 Siglecs	 and	 not	 chimpanzee	 orthologs,	 modulating	 host	 immune	
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1  | INTRODUC TION
Gonorrhea	 is	 a	 sexually	 transmitted	 disease	 that	 poses	 a	 major	
global	 health	 problem,	 with	 about	 78	million	 estimated	 infections	
worldwide	in	2012	(Newman	et	al.,	2015).	This	disease	is	caused	by	










evade	the	host	 immune	response.	The	 lacto‐N‐neotetraose	 (LNnT)	
structure	of	the	LOS	engages	host	surface	receptors,	 like	the	asia‐
loglycoprotein	receptor	 (ASGP‐R),	and	 leads	to	the	 invasion	of	the	
urethral	epithelia	(Harvey,	Jennings,	Campbell,	Williams,	&	Apicella,	
2001).	 Sialic	 acid,	 a	 9‐carbon	 backbone	 acidic	 sugar,	 plays	 an	 im‐
portant	 role	 during	 the	 infection	 of	 many	 human‐specific	 patho‐
gens	(Hentrich	et	al.,	2016;	Patrone	&	Stein,	2007;	Varki	&	Gagneux,	
2012).	 The	 gonococcal	 LNnT	 structure	 becomes	 sialylated	 by	 the	
gonococcal	 sialyltransferase	 (Lst),	 a	 surface‐exposed	 outer	 mem‐



















with	 similar	 ligand	 specificities	 but	 opposite	 signaling	 properties.	
For	 instance,	the	Siglec‐5/‐14	and	Siglec‐11/‐16	pairs	have	a	highly	
conserved	 extracellular	 domain	 and	 similar	 ligand	 specificities	
(Angata,	 Hayakawa,	 Yamanaka,	 Varki,	 &	 Nakamura,	 2006;	 Cao	 et	
al.,	2008;	Schwarz,	Fong,	&	Varki,	2015;	Wang,	Mitra,	Cruz,	et	al.,	
2012).	Activating	Siglecs	recruit	adaptor	proteins	such	as	DAP10	and	





gested	 that	activating	Siglecs	 represent	evolutionary	 responses	 to	
microbes	 exploiting	 inhibitory	 Siglecs.	 In	 fact,	 Siglec‐14	 has	 been	
shown	to	counteract	the	exploitation	of	Siglec‐5	by	GBS	(Ali	et	al.,	








alic	 acid‐dependent	 and	 sialic	 acid‐independent	 interactions	 with	





2  | MATERIAL S AND METHODS
2.1 | Bacteria and cell lines
Neisseria gonorrhoeae	 F62	was	 isolated	 from	 an	 uncomplicated	 in‐
fection	(Kellogg,	Peacock,	Deacon,	Brown,	&	Pirkel,	1963).	Neisseria 
gonorrhoeae	 15253	 was	 isolated	 from	 a	 disseminated	 infection	
(O'Brien,	Goldenberg,	&	Rice,	1983).	Both	strains	were	piliated.	The	
mutant	 strains	 of	 F62	 (ΔlgtD,	ΔlgtA,	ΔlgtE,	 and	ΔlgtF)	were	 con‐
structed	using	plasmids	and	methods	described	previously	(Gulati	et	
al.,	2015).	The	LOS	phenotype	of	the	mutants	was	verified	by	LOS	
staining	of	protease	K‐treated	whole‐cell	 samples	 that	were	 sepa‐
rated	on	a	12%	Bis–Tris	gel	with	MES	running	buffer.	N. gonorrhoeae 
were	grown	overnight	on	chocolate	agar	plates	with	IsoVitaleX	(BD	
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30	µM	CMP‐Neu5Ac	 (Nacalai	USA,	 Inc.).	 Incorporation	of	Neu5Ac	







Siglec‐Fcs	 were	 produced	 as	 described	 in	 Padler‐Karavani	 et	 al.	
(2014).	 Siglec‐Fc	 vectors	 were	 transfected	 into	 HEK293A	 cells	
cultured	 in	 serum‐free	 media	 supplemented	 with	 Nutridoma‐SP	
(Roche).	Culture	 supernatants	were	collected,	and	Siglec‐Fcs	were	












were	 washed	 with	 PBS‐T	 (0.05%	 Tween‐20	 in	 PBS)	 and	 blocked	
with	1%	BSA	in	PBS	for	1	hr	at	room	temperature.	1	μg/well	Siglec‐
Fcs	 were	 incubated	 for	 2	hr	 at	 room	 temperature.	 To	 correct	 for	
unspecific	 binding	 of	 Fc	 part,	 human	 IgG	was	 incubated	 in	 paral‐
lel.	Afterward,	wells	were	washed	with	PBS‐T.	N. gonorrhoeae were 
pelleted,	 washed	with	 HBSS,	 and	 then	 incubated	with	 0.1%	 fluo‐
rescein	 isothiocyanate	 (FITC,	 Sigma)	 in	PBS	 for	1	hr	 at	37	 ˚C	with	
rotation.	 Bacteria	were	 extensively	washed	with	HBSS	 to	 remove	












2.4 | Binding assays to porins
Ninety‐six‐well	 plates	 were	 coated	 with	 1	μg/well	 of	 purified	
PorinB.1A	 and	 PorinB.1B.	 Purified	 porins	 are	 in	 their	 native	 trim‐
eric	state	in	proteosomes	and	purified	as	described	in	Ref.	Massari,	
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King,	MacLeod,	and	Wetzler	 (2005)	or	purified	 IgA‐Br	as	negative	
control	(Fong	et	al.,	2015)	in	50	mM	carbonate	buffer	pH	9.5	over‐
night	 at	 4°C.	Wells	were	washed	with	 PBS‐T	 (0.05%	Tween‐20	 in	
PBS)	 and	 blocked	with	 1%	BSA	 in	 PBS	 for	 1	hr	 at	 room	 tempera‐
ture.	Wells	were	washed	and	incubated	with	5	µg/ml	Siglec‐Fc	in	1%	
BSA	PBS‐T	 for	2	hr	at	 room	 temperature.	Wells	were	washed	and	
incubated	with	goat	HRP‐conjugated	anti‐human	IgG	(1:5,000	dilu‐





THP‐1	 cells	 expressing	 Siglec‐5	 or	 Siglec‐14	 (Yamanaka,	 Kato,	
Angata,	&	Narimatsu,	2009)	were	differentiated	with	10	ng/ml	PMA	
in	a	24‐well	plate	for	24	hr	and	infected	with	MOI	=	1	of	the	same	




THP‐1	 cells	 transduced	 with	 an	 expression	 plasmid	 for	 Siglec‐5,	
Siglec‐14,	 or	 empty	 vector	were	 differentiated	with	 12.5	ng/ml	 of	
phorbol	 myristate	 acetate	 (PMA)	 for	 24	hr.	 Next,	 the	 cells	 were	
washed	with	sterile	culture	media,	blocking	or	nonblocking	antibod‐
ies	were	 added,	 and	 then	 exposed	 to	 10	µg/ml	 of	 PIB	 for	 10	min	
before	the	addition	of	pHrodo	Red	S. aureus	BioParticles	(prepared	
as	per	manufacturer's	instructions,	Thermo	Fisher	Scientific).	After	
incubation	 at	 37°C	 for	 2	hr,	 the	 cells	 were	washed	with	 PBS	 and	
then	 detached	with	 5	mM	EDTA	 in	 PBS.	 The	 detached	 cells	were	
centrifuged	for	5	min	at	500	g	and	washed	with	PBS.	After	another	
centrifugation,	 the	cells	were	resuspended	 in	PBS	and	assayed	for	













test	and	represented	as	mean	±	SD,	n = 3. 
(c–g)	Binding	of	human	Siglec‐Fcs	to	F62	
mutants	where	genes	that	encoded	the	
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Samples	 used	 for	 immunohistochemistry	 were	 heterozygous	 for	
Siglec‐16	 or	 homozygous	 null	 (negative	 control).	 All	 three	 human	
cervix	 samples	 that	 were	 used	 had	 both	 squamous	 epithelium	
and	 columnar	 epithelium	 as	 well	 as	 the	 junctional	 zone.	 Samples	
of	 human	 spleen	 similarly	 either	 heterozygous	 for	 Siglec‐16	 (posi‐
tive	control)	or	homozygous	null	 (negative	control)	were	used	with	
every	experiment.	Deparaffinized	sections	were	blocked	for	endog‐
enous	 peroxidases	 and	 endogenous	 biotin	 and	 subjected	 to	 heat‐
induced	antigen	 retrieval	using	pH	9.0	buffer	and	pressure	cooker	
de‐cloaking	chamber	 (Biocare	Medical)	 for	15	min	at	110	degrees.	
After	 the	 slides	 cooled	 to	 37°C,	 the	 sections	 were	 overlaid	 with	




ther	 HRP‐Streptavidin	 again	 or	 fluorescently	 labeled	 streptavidin.	
If	HRP‐Streptavidin	was	the	final	step,	the	substrate	used	for	color	
development	was	AEC	(Vector	 laboratories)	and	nuclei	were	coun‐
terstained	with	Mayer's	 hematoxylin	 and	 the	 slides	were	 aqueous	
mounted	for	viewing	and	photography	using	a	Olympus	Magnafire	




2.8 | Genotyping of Siglecs in Namibian cohort
Genomic	 DNA	 was	 isolated	 from	 FTA	 cards	 of	 Namibian	 cohort	
(Hazel,	Ponnaluri‐Wears,	Davis,	Low,	&	Foxman,	2014)	with	E.Z.N.A.	
MicroElute	 Genomic	 DNA	 Kit	 (OMEGA).	 The	 participants	 of	 the	
Namibian	cohort	 study	were	 randomly	 selected	and	not	based	on	
any	reported	symptoms.	Genotyping	of	the	Siglec‐3	polymorphism	
rs3865444	was	 performed	 as	 described	 in	 Schwarz	 et	 al.	 (2016).	
Genotyping	of	Siglec‐5	and	Siglec‐14	was	performed	as	described	in	
Yamanaka	et	al.	(2009).	Genotyping	of	Siglec‐16	was	performed	by	PCR	
with	 primers	 (forward:	 GCATGTCTGATCACCTCAGTTGGGAAAG;	
reverse:	 CCCTGACTCTCCTGTACTGATAAACC)	 and	 OneTaq	
MasterMix	 (New	 England	 Biolabs).	 Followed	 by	 restriction	 digest	
with	 TspRI	 (New	 England	 Biolabs),	 which	 cuts	 a	 polymorphism	
(Wang,	 Mitra,	 Secundino,	 et	 al.,	 2012)	 in	 disequilibrium	 with	 the	
SIGLEC16P.
2.9 | Statistical analysis
Prism	 6	 software	 (GraphPad)	 was	 used	 for	 statistical	 analyses	 of	




Gene	 Association	 Analysis:	 Gene–disease	 association	 was	 as‐
sessed	between	binary	 variables	 representing	 each	genotype	 (ho‐
mozygous	 dominant,	 heterozygous,	 homozygous	 recessive)	 of	 the	
three	loci	(Siglec‐3,	Siglec‐16,	and	Siglec‐5/14),	and	we	used	models	
considering	 the	 presence	 or	 absence	 of	 each	 genotype.	 Standard	
genetic	models	of	dominant,	recessive,	additive,	and	epistatic	were	
examined	but	discarded	due	to	overfitting.	The	unusually	high	fre‐
quency	 of	 disease	 mutations	 seen	 in	 Namibian	 cohort	 interfered	








































































rophages	 express	 Siglec‐3,	 Siglec‐11,	 and	 Siglec‐16.	 Some	 Siglecs	
also	 have	 been	 found	 on	 other	 cell	 types;	 for	 example,	 Siglec‐11	
on	 ovarian	 fibroblasts	 (Wang	 et	 al.,	 2011),	 Siglec‐5	 on	 human	 but	
not	chimpanzee	amniotic	epithelia	(Ali	et	al.,	2014),	and	Siglec‐6	on	
human	placental	 trophoblast,	but	not	 in	great	apes	 (Brinkman‐Van	
der	 Linden	 et	 al.,	 2007).	 The	 primary	 site	 of	 gonococcal	 infection	
in	 women	 is	 the	 endocervical	 epithelium.	 We	 detected	 Siglec‐11	







which	 downregulates	 the	 pro‐inflammatory	 response	 and	 enables	




receptor,	Siglec‐16	could	enable	 the	host	 to	detect	N. gonorrhoeae 
and	 mount	 a	 pro‐inflammatory	 immune	 response	 that	 results	 in	
symptoms	and	facilitates	clearance	of	bacteria.
3.2 | Neisseria gonorrhoeae selectively engages 
human Siglec receptors
Natural	infection	with	N. gonorrhoeae occurs	exclusively	in	humans.	
Siglecs	 are	 widely	 expressed	 on	 cell	 surfaces	 of	 innate	 immune	
cells	 such	as	macrophages	and	neutrophils,	which	produce	key	 in‐
nate	 immune	 responses	 to	gonococcal	 infections	 (Virji,	2009).	We	
focused	on	Siglecs	3,	5,	9,	11,	14,	and	16,	which	are	prominent	ex‐
amples	 of	 Siglecs	 expressed	 by	 phagocytes	 and/or	 epithelial	 cells	
that	are	relevant	to	gonococcal	 infection	 in	humans.	To	determine	
whether	gonococci	 interact	with	Siglecs	 in	 a	human‐specific	man‐
ner	that	may	contribute	to	its	human	specificity,	we	compared	bind‐
ing	 of	 recombinant	 soluble	 extracellular	 domains	 of	 human	 and	
chimpanzee	 homologs	 (fused	with	 Ig‐Fc)	 to	N. gonorrhoeae	 strains	
F62	and	15253	 (Figure	2).	While	 strain	F62	can	express	 the	LNnT	
LOS	epitope	 that	 can	be	 terminally	 substituted	with	 sialic	 acid	via	
an α2‐3	 linkage	 (Yamasaki,	Nasholds,	Schneider,	&	Apicella,	1991),	
strain	15253	lacks	the	genes	that	encode	LOS	glycosyltransferases	
LgtB,	LgtC,	and	LgtD	(Erwin,	Haynes,	Rice,	&	Gotschlich,	1996)	and	
thus	 can	 expresses	 LOS	 structures	 with	 only	 lactose	 extensions	
from	HepI	and	HepII	(Supporting	Information	Figure	S6a)	(Mandrell,	
Griffiss,	 Smith,	 &	 Cole,	 1993).	While	 human	 Siglec‐3	 (also	 known	
as	CD33)	bound	strongly	to	strain	F62	(grown	in	media	containing	




(p	=	0.010)	 also	 showing	a	 significantly	 increased	binding	over	 the	
chimpanzee	 homologs.	 The	 N. gonorrhoeae PorB.1A	 strain	 15253,	
which	 was	 isolated	 from	 a	 disseminated	 infection,	 bound	 signifi‐
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Amino	acid	sequence	differences,	as	well	as	differences	in	post‐
translational	modifications	such	as	N‐	and	O‐glycosylation	between	
the	 human	 and	 chimpanzee	 homologs,	 could	 be	 responsible	 for	
the	 difference	 in	 binding	 (Supporting	 Information	 Figures	 S2–S5).	
Differences	 in	patterns	of	Siglec	binding	between	 the	 strains	may	
also	be	due	to	differences	in	the	LOS	structure	(Figure	3a),	 includ‐
ing	 sialylation,	 and/or	 other	 surface	 structures	 that	 could	 modify	
interactions.
3.3 | Neisseria gonorrhoeae binding to Siglecs is 
only partially dependent on LOS sialic acid, and 
truncation of LOS increases binding
Since	Siglecs	are	lectins	that	usually	bind	to	sialic	acid,	we	hypoth‐
esized	that	the	sialylated	LOS	on	N. gonorrhoeae (Figure	3a)	is	likely	
the	 primary	 ligand	 for	 Siglecs.	Growth	 of	N. gonorrhoeae in media 
lacking	CMP‐Neu5Ac	leads	to	expression	of	non‐sialylated	LOS	be‐
cause	 gonococci	 lack	 the	 ability	 to	 synthesize	 sialic	 acid	 de	 novo; 
the	addition	of	CMP‐Neu5Ac	to	media	results	in	sialylation	of	LNnT	
LOS	 (Mandrell,	 Smith,	 et	 al.,	 1993;	 Nairn	 et	 al.,	 1988;	 Supporting	
Information	Figure	S1).	The	binding	of	sialylated	and	non‐sialylated	
gonococci	 F62	 indeed	 differs	 with	 some	 Siglecs	 (Figure	 3b).	 The	
binding	 of	 Siglec‐3	 (p	<	0.001)	 is	 solely	 dependent	 on	 sialic	 acid.	
The	 binding	 of	 Siglec‐9	 (p	=	0.016)	 and	 Siglec‐14	 (p	=	0.004)	 was	












flow	 cytometry	 to	 isogenic	 mutants	 of	 strain	 F62	 that	 expressed	
truncated	 LOS	 glycans	 by	 (separately)	 inactivating	 the	 LOS	 glyco‐
syltransferases	 lgtD, lgtA, lgtE, and lgtF	 (Figure	 3a).	 Progressive	





the	 strongest	 to	 the	mutant	with	 the	exposed	 (unsialylated)	 LNnT	
structure	(Figure	3g).	These	data	suggest	the	presence	of	an	alter‐
nate	ligand	on	N. gonorrhoeae	for	Siglecs.	When	present,	sialylated	
LOS	may	be	 the	primary	binding	 site	 for	LOS.	 In	contrast,	 as	with	
Siglec‐11	and	Siglec‐16,	sialylated	LNnT	LOS	may	actually	hinder	ac‐
cess	of	 the	 alternate	 ligand	 to	Siglecs.	However,	when	LOS	phase	
varies	 (e.g.,	 lgtA	 “off”),	 it	may	 leave	 the	 alternate	 ligand	more	 ex‐
posed	and	permit	binding	to	Siglecs.
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3.4 | Gonococcal Porin B mediates binding to 
human Siglecs in a protein‐dependent manner
In	addition	to	their	main	sialylated	ligands,	some	Siglecs	have	been	
reported	 to	 engage	 in	 protein–protein	 interactions	 (Carlin	 et	 al.,	
2009;	Fong	et	al.,	2015).	Porin	B	(PorB)	is	the	major	outer	membrane	
protein	 of	N. gonorrhoeae	 and	 is	 essential	 for	 gonococcal	 survival.	
We	 have	 shown	 previously	 that	 LOS	 structure	modulates	 binding	
of	 the	complement	 inhibitor	C4BP	to	PorB	 (Ram	et	al.,	2007).	We	
did	not	expect	the	unsialylated	glycans	expressed	by	the	gonococcal	
LOS	mutants	tested	in	Figure	3c‐g	above	to	directly	bind	to	Siglecs,	










The	 binding	 patterns	 of	 PorB.1A	 and	PorB.1B	were	 similar,	which	
could	 indicate	 a	 conserved	 binding	 region	 or	 motif	 between	 the	
two	porins.	The	preference	of	porins	to	bind	to	human	Siglecs	over	







3.5 | Neisseria gonorrhoeae modulates innate 
immune response via engagement of Siglecs
The	innate	immune	system	plays	an	important	role	in	the	symptom‐
atology	of	 gonorrhea;	 the	 lack	of	 a	 robust	 inflammatory	 response	
contributes	to	the	 lack	of	symptoms	that	 is	commonly	seen,	espe‐
cially	 in	 women.	 Monocytes	 and	 macrophages	 are	 an	 important	
source	of	inflammatory	cytokines.	Multiple	attempts	to	establish	an	
immortalized	cell	 line	expressing	Siglec‐11	and	Siglec‐16	or	human	
monocytes	 as	model	 system	 failed.	 To	 investigate	whether	 Siglec	






F I G U R E  7  Possible	mechanism	
of	Siglec	gonococci	interactions.	
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By	contrast,	expression	of	the	activating	Siglec‐14	increased	IL‐6	se‐
cretion	(p	=	0.043).	IL‐6	is	a	major	pro‐inflammatory	cytokine,	plays	





PorB.1B.	 Increased	 phagocytic	 activity	 was	 seen	 when	 Siglec‐14‐
expressing	 THP‐1	 cells	 were	 incubated	 with	 PorB.1B	 (p	=	0.009).	
The	 addition	 of	 a	 Siglec‐14	blocking	 antibody	 reversed	 this	 effect	
(p	=	0.002),	 suggesting	 a	 functional	 interaction	 between	 Siglec‐14	
and	PorB	 is	a	direct	physical	contact	 (Figure	5b).	These	 results	 in‐
dicate	 that	 gonococcal	 engagement	 of	 inhibitory	 Siglecs	 such	 as	
Siglec‐5	 could	 contribute	 to	 inhibition	 of	 pro‐inflammatory	 re‐
sponses,	as	seen	 in	asymptomatic	disease.	On	the	other	hand,	en‐
gagement	of	activating	Siglecs,	such	as	Siglec‐14,	can	contribute	to	
the	 pro‐inflammatory	 response	 that	 could	 help	 clear	 gonococcal	
infection.
3.6 | Genetic polymorphisms in human Siglecs can 
influence burden of Neisseria gonorrhoeae
Similar	to	Siglec‐16,	Siglec‐14	is	also	not	expressed	in	every	individual	
(Yamanaka	et	al.,	2009).	The	absence	of	these	activating	receptors	
could	 contribute	 to	 asymptomatic	 disease	 and	 prolonged	 carriage	





associated	with	 lower	expression	of	 this	 isoform.	Therefore,	 the	C	
allele	potentially	reduces	pro‐inflammatory	responses	by	providing	
gonococci	with	more	exploitable	inhibitory	Siglec‐3	receptors.
To	 test	whether	 these	 genetic	 variations	 in	 human	 Siglecs	 are	
associated	with	gonococcal	 infections,	we	genotyped	a	human	co‐







In	 this	 cohort,	 we	 found	 that	 infected	 females	 express	 the	
Siglec‐16	 receptor	 less	 frequently	with	 an	 allele	 frequency	 of	 the	


















tection	or	 risk	 for	 the	different	genotypes	 in	males	 (Figure	6b).	 In	
an	 additive	 model	 of	 homozygous	 Siglec‐14	 wt	 and	 Siglec‐16	 wt,	
Siglec‐16	 again	 showed	 again	 significant	 protection	 with	 an	 odds	
ratio	 of	 0.089	 (p	=	0.032;	 CI	=	0.004–0.620);	 however,	 Siglec‐14	











Neisseria gonorrhoeae	 has	 evolved	 a	 variety	 of	 strategies	 to	 infect	
the	human	host	and	exploit	its	immune	system	(Edwards	&	Apicella,	
2004).	In	this	study,	we	present	a	new	mechanism	whereby	N. gonor‐











including	 specificity	 for	human	CEACAMs	 (Pils,	Gerrard,	Meyer,	&	
Hauck,	2008;	Sadarangani,	Pollard,	&	Gray‐Owen,	2011;	Sintsova	et	
al.,	 2015;	 Voges,	 Bachmann,	 Kammerer,	Gophna,	&	Hauck,	 2010),	
the	ability	to	utilize	transferrin	as	an	iron	source	from	humans	and	
only	 certain	non‐human	primates	 (Gray‐Owen	&	Schryvers,	 1993)	
and	 the	 inability	 to	 evade	 non‐human	 complement	 because	 of	 its	
selective	binding	to	the	human	complement	inhibitors,	factor	H	and	
C4b‐binding	 protein	 (C4BP)	 (Ngampasutadol	 et	 al.,	 2005,	 2008).	
Our	results	show	that	N. gonorrhoeae	binds	preferentially	to	human	
Siglecs,	which	may	be	another	reason	for	its	human	specificity.
Apart	 from	 these	 evolutionary	 considerations,	 the	 data	 pre‐
sented	in	this	work	suggest	that	interaction	of	N. gonorrhoeae with	
346  |     LANDIG et AL.




infection	and	 contribute	 to	 the	 relative	paucity	of	 symptoms.	The	
engagement	 of	 activating	 Siglec	 receptors,	 such	 as	 Siglec‐14	 and	
Siglec‐16,	 leads	 to	 an	 activation	of	 the	pro‐inflammatory	 signaling	
cascade	that	facilitates	clearance	of	gonococcal	infection.	However,	
these	activating	receptors	are	not	present	on	all	 individuals,	which	
may	 account,	 at	 least	 in	 part,	 for	 differences	 across	 individuals	 in	
their	ability	to	clear	gonococcal	infections.
The	 role	 of	 pro‐inflammatory	 responses	 in	 gonococcal	 patho‐
genesis	 remains	 controversial	 (Criss	 &	 Seifert,	 2012;	 Virji,	 2009).	
While	activating	receptors	such	as	Siglec‐14	and	Siglec‐16	may	con‐
tribute	to	a	pro‐inflammatory	response	following	infection	facilitate	
clearance	 of	 infection,	 N. gonorrhoeae	 have	 developed	 numerous	
mechanisms	to	survive	within	neutrophils	that	are	abundant	at	the	





related	with	 a	 lower	 burden	 of	 gonorrhea	 in	 females.	 Siglec‐16	 is	




ing	Siglec‐14,	which	 is	only	expressed	on	neutrophils.	 It	 is	 intrigu‐





(ASGP‐R;	Harvey	et	 al.,	 2001).	 The	 ability	of	 Siglec‐16	 to	 respond	
to	 unsialylated	 gonococci	 may	 represent	 an	 evolutionary	 mech‐
anism	 that	 permits	 the	host	 to	 adapt	 to	 gonococci	whose	 surface	
has	been	modified	by	sialidases	elaborated	by	cohabiting	microbial	








typhi‐mediated	 typhoid	 fever	 and	Plasmodium falciparum malaria 





excess	 in	 humans.	While	 no	pathogens	 are	 known	 to	 synthesize	
Neu5Gc,	 other	 human	 pathogens	 have	 independently	 evolved	
convergent	ways	to	coat	themselves	with	Neu5Ac	containing	gly‐
cans,	 and	 thereby	 evade	 the	 innate	 immune	 response	 via	multi‐
ple	 mechanisms,	 including	 the	 engagement	 of	 inhibitory	 Siglecs	
on	 innate	 immune	cells	 (Chang	&	Nizet,	2014;	Varki	&	Gagneux,	
2012;	 Vimr,	 Kalivoda,	 Deszo,	 &	 Steenbergen,	 2004).	 Two	 such	
documented	examples	include	human‐specific	pathogens	group	B	
streptococcus	which	engages	Siglec‐9	on	neutrophils	and	Siglec‐5	
on	 the	 amniotic	 epithelium	 (Ali	 et	 al.,	 2014;	 Carlin	 et	 al.,	 2007)	
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